Expression of neuropeptides and other neuroendocrine markers in human phaeochromocytomas

Neuropeptides

Volumn 33, Issue 2, 1999, Pages 159-163

  Moreno, A M ^a,c   Castilla Guerra, L ^b   Martinez Torres M C ^a   Torres Olivera, F ^a   Fernandez E ^a   Galera Davidson, H ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CHROMOGRANIN A; CORTICOTROPIN; NEURON SPECIFIC ENOLASE; NEUROPEPTIDE; SOMATOSTATIN; SYNAPTOPHYSIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FAMILIAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIPLE ENDOCRINE NEOPLASIA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

EID: 0033120654     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0012     Document Type: Article

References (27)

1. CApella C, Riva C, Cornaggia M, Chiaravalli AM, Frigerio B. Histopathology, cytology and cytochemistry of phaeochromocytomas and paragangliomas including chemodectomas. Path Res Pract 1988; 183: 176-187.
2. Ricardi VM. Von recklinhausen neurofibromatosis. N Engl J Med 1981; 305: 1617-1626.
3. Nibbelink DW, Peters BH, McCormick WF. On the association of phaeochromocytoma and cerebellar hemangioblastoma. Neurology 1969; 19: 455-460.
4. Melicow MM. One hundred cases of phaeochromocytoma (107 tumours) at the columbia-prebysterian medical center, 1926-1976. A clinico-pathological analysis. Cancer 1977; 40: 1987-2004.
5. Lloyd RL, Shapiro B, Sisson JC, Kalff V Thompson NW, Beier-Waltes WA. An immunohistochemical study of pheochrmocytomas. Arch Pathol Lab Med 1984; 108: 541-544.
6. Lehto VP, Virtanen I, MIettinen M, DAhl D, Kahri A. Neurofilament in adrenal and extra-adrenal phaeochromocytoma. Arch Pathol Lab Med 1983; 107: 492-494.
7. Rindi G, Buffa R, Sessa F, Tortora O, Solcia E. Chromogranin A, B and C immunoreactivities of mamalian endocrine cells. Distribution, distinction from costored hormones/prohormones and relationship with argyrophil components of secretory granules. Histochemistry 1986; 85: 19-28.
8. Syversen U, Waldum HL, O'Connor DT. Rapid, high-yield isolation of human chromogranin A from chromaffin granules of phaeochromocytomas. Neuropeptides 1992; 22: 235-240.
9. Armitage BG. Statistical Methods in Medical Research. 2nd Ed. Oxford, Blackwell 1987.
10. Willians RH. Textbook Of Endocrinology 7 Ed. Philadelphia, London, Toronto, Saunders 1988.
11. MIettinen M, Pekka V, Virtanen I. Immunofluorescence microscopic evaluation of the intermediate filament expression of the adrenal cortex and medulla and their tumours. Am J Pathol 1985; 118: 360-366.
12. Schmechel D, Marangos PJ, Brightman M. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978; 276: 834-836.
13. Haimoto M, Takahashi Y, Koshikawa T, Nagura H, Kato K. Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 1985; 52: 257-263.
14. Leader M, Collins M, Patel J, Henry K. Antineuron specific enolase staining reactions in sarcomas and carcinomas: Its lack of neuroendocrine specificity. J Clin Pathol 1986; 39: 1186-1192.
15. Montresor E, Iacono C, Nifosi F et al. Retroperitoneal paragangliomas: Role of immunohistochemistry in the diagnosis of malignancy and in assessment of prognosis. Eur J Surg 1994; 160: 547-552.
16. Miettinen M. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumours. Arch Pathol Lab Med 1987; 11: 813-818.
17. Eriksson B, Arnberg H, Oberg K et al. A polyclonal antiserum against chromogranin A and B - A new marker for neuroendocrine tumours. Acta Endocrinol (Cop) 1990; 122: 145-155.
18. Fraga M, Garcia-Caballero T, Antúnez J, Couce M, Beiras A, Forteza J. A comparative immunohistochemical study of phaechromocytomas and paragangliomas. Histol Histopath 1993; 8: 429-436.
19. Unger PD, Huffman K, Thung SN, Pertsemlides D, Wolfe D, Kaneko M. HMB-45 reactivity in adrenal phaeochromocytomas. Arch Pathol Lab Med 1992; 116: 151-153.
20. Linnoila RI, Lack EE, Steinberg SM, Keiser HR. Decreased expression of neuropeptides in malignant paragangliomas: An immunohistochemical study. Human Pathol 1988; 19: 41-49
21. Ivanova RS, Dashev GI. Neuroendocrine features of sdrenal phaeochromocytomas. Histological and immunocytochemical evaluation. Neoplasma 1989; 37: 219-224.
22. Hartmann CA, Gross U, Stein H. Gushing syndrome-associated phaeochromocytoma and adrenal carcinoma. An immunohistological investigation. Pathol Res Pract 1992; 188: 287-295.
23. Wirnsberger GH, Becker H, Ziervogel K, Hofler H. Diagnostic immunohistochemistry of neuroblastic tumours. Am J Surg Pathol 1992; 16; 49-57.
24. Schmid KW, Dockhorn-Dwornizak B, Fahrenkamp A, et al. Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas. Histopathology 1993. 22: 527-33.
25. Herrera MF, Stone E, Deitel M, Asa SL. Phaeochromocytoma producing multiple vasoactive peptides. Arch Surg 1992; 127: 105-108.
26. Saeger W, Reincke M, Scholz GH, Ludecke DK. Ectopic ACTH or crh-secreting tumours in cushin's syndrome. Zentralbl Pathol 1993; 139: 157-163.
27. Hanna FW, Ardill JE, Johnston CF et al. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid. J Endocrinol 1997; 152: 275-281.